GENETIC-ANALYSIS OF THE COFACTOR REQUIREMENT FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT FUNCTION

被引:123
|
作者
MADORE, SJ
CULLEN, BR
机构
[1] DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,GENET SECT,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT MICROBIOL,DURHAM,NC 27710
关键词
D O I
10.1128/JVI.67.7.3703-3711.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Tat protein of human immunodeficiency virus type 1 is a potent transcriptional trans activator of the viral long terminal repeat promoter element. Tat function requires the direct interaction of Tat with a cis-acting viral RNA target sequence termed the trans-activation response (TAR) element and has also been proposed to require at least one cellular cofactor. We have used a genetic approach to attempt to experimentally define the role of the cellular cofactor in Tat function and TAR binding. Our data suggest that neither Tat nor the cellular cofactor binds to TAR alone in vivo and indicate, instead, that the interaction of Tat with its cellular cofactor is a prerequisite for TAR binding. The known species tropism of lentivirus Tat proteins appears to arise from the fact that not only Tat but also the cellular cofactor can markedly influence the RNA sequence specificity of the resultant protein complex. These data also suggest that the Tat cofactor is likely a cellular transcription factor that has been highly conserved during vertebrate evolution. We hypothesize that the primary function of Tat is to redirect this cellular factor to a novel viral RNA target site and to thereby induce activation of viral gene expression.
引用
下载
收藏
页码:3703 / 3711
页数:9
相关论文
共 50 条
  • [21] GENETIC-ANALYSIS OF HOMOMERIC INTERACTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE USING THE YEAST 2-HYBRID SYSTEM
    KALPANA, GV
    GOFF, SP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) : 10593 - 10597
  • [22] REQUIREMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF FOR IN-VIVO REPLICATION AND PATHOGENICITY
    JAMIESON, BD
    ALDROVANDI, GM
    PLANELLES, V
    JOWETT, JBM
    GAO, LY
    BLOCH, LM
    CHEN, ISY
    ZACK, JA
    JOURNAL OF VIROLOGY, 1994, 68 (06) : 3478 - 3485
  • [23] MUTATIONAL ANALYSIS OF THE CONSERVED CYSTEINE-RICH REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN
    RICE, AP
    CARLOTTI, F
    JOURNAL OF VIROLOGY, 1990, 64 (04) : 1864 - 1868
  • [24] INTERACTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT-DERIVED PEPTIDES WITH TAR RNA
    LONG, KS
    CROTHERS, DM
    BIOCHEMISTRY, 1995, 34 (27) : 8885 - 8895
  • [25] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT ACTIVITY BY COEXPRESSION OF HETEROLOGOUS TRANS ACTIVATORS
    CARROLL, R
    PETERLIN, BM
    DERSE, D
    JOURNAL OF VIROLOGY, 1992, 66 (04) : 2000 - 2007
  • [26] RECIPROCAL MODULATIONS BETWEEN P53 AND TAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LI, CJ
    WANG, CL
    FRIEDMAN, DJ
    PARDEE, AB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5461 - 5464
  • [27] FUNCTIONAL-ANALYSIS OF THE N-TERMINAL DOMAIN OF TAT PROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    REDDY, MVR
    DESAI, M
    JEYAPAUL, J
    PRASAD, DDK
    SESHAMMA, T
    PALMERI, D
    KHAN, SA
    ONCOGENE, 1992, 7 (09) : 1743 - 1748
  • [28] RANDOM MUTAGENESIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSACTIVATOR OF TRANSCRIPTION (HIV-1 TAT)
    SIDEROVSKI, DP
    MATSUYAMA, T
    FRIGERIO, E
    CHUI, S
    MIN, X
    ERFLE, H
    SUMNERSMITH, M
    BARNETT, RW
    MAK, TW
    NUCLEIC ACIDS RESEARCH, 1992, 20 (20) : 5311 - 5320
  • [29] GENETIC DIVERSITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS IN KINSHASA, ZAIRE
    POTTS, KE
    KALISH, ML
    BANDEA, CI
    ORLOFF, GM
    STLOUIS, M
    BROWN, C
    MALANDA, N
    KAVUKA, M
    SCHOCHETMAN, G
    OU, CY
    HEYWARD, WL
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (07) : 613 - 618
  • [30] COMPARATIVE-ANALYSIS OF REV FUNCTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    GARRETT, ED
    CULLEN, BR
    JOURNAL OF VIROLOGY, 1992, 66 (07) : 4288 - 4294